Literature DB >> 9430909

Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.

F al-Hawas, A H Abdalla, W Popovich, D H Mousa, M H al-Sulaiman, A A al-Khader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9430909     DOI： 10.1093/ndt/12.12.2801

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.

Authors:  Kazuya Takasawa; Chikako Takaeda; Takashi Wada; Norishi Ueda
Journal:  Nutrients       Date:  2018-03-29       Impact factor: 5.717

Review 2.  Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Norishi Ueda; Kazuya Takasawa
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.